• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023

    3/17/23 11:00:48 AM ET
    $AAL
    $AIT
    $ATAT
    $BBWI
    Air Freight/Delivery Services
    Consumer Discretionary
    Industrial Specialties
    Consumer Discretionary
    Get the next $AAL alert in real time by email

    Upgrades

    Redburn Partners upgraded the previous rating for FMC Corp (NYSE:FMC) from Neutral to Buy. For the fourth quarter, FMC had an EPS of $2.37, compared to year-ago quarter EPS of $2.16. The stock has a 52-week-high of $140.82 and a 52-week-low of $98.24. At the end of the last trading period, FMC closed at $116.76.

    Piper Sandler upgraded the previous rating for Columbia Banking System Inc (NASDAQ:COLB) from Neutral to Overweight. For the fourth quarter, Columbia Banking System had an EPS of $0.88, compared to year-ago quarter EPS of $0.55. The stock has a 52-week-high of $35.53 and a 52-week-low of $20.25. At the end of the last trading period, Columbia Banking System closed at $21.94.

    Seaport Global upgraded the previous rating for Duke Energy Corp (NYSE:DUK) from Sell to Neutral. For the fourth quarter, Duke Energy had an EPS of $1.11, compared to year-ago quarter EPS of $0.88. The stock has a 52-week-high of $116.33 and a 52-week-low of $83.78. At the end of the last trading period, Duke Energy closed at $97.20.

    According to Wolfe Research, the prior rating for Warner Bros. Discovery Inc (NASDAQ:WBD) was changed from Peer Perform to Outperform. In the fourth quarter, Warner Bros. Discovery showed an EPS of $0.37, compared to $0.08 from the year-ago quarter. The stock has a 52-week-high of $27.50 and a 52-week-low of $8.82. At the end of the last trading period, Warner Bros. Discovery closed at $14.16.

    According to Wolfe Research, the prior rating for American Airlines Group Inc (NASDAQ:AAL) was changed from Underperform to Peer Perform. American Airlines Group earned $1.17 in the fourth quarter, compared to $1.42 in the year-ago quarter. At the moment, the stock has a 52-week-high of $21.42 and a 52-week-low of $11.65. American Airlines Group closed at $14.12 at the end of the last trading period.

    For GDS Holdings Ltd (NASDAQ:GDS), Deutsche Bank upgraded the previous rating of Hold to Buy. In the fourth quarter, GDS Holdings showed an EPS of $0.15, compared to $0.30 from the year-ago quarter. The stock has a 52-week-high of $48.39 and a 52-week-low of $8.41. At the end of the last trading period, GDS Holdings closed at $16.24.

    Piper Sandler upgraded the previous rating for Sterling Bancorp Inc (NASDAQ:SBT) from Neutral to Overweight. For the fourth quarter, Sterling Bancorp had an EPS of $0.00, compared to year-ago quarter EPS of $0.10. At the moment, the stock has a 52-week-high of $7.16 and a 52-week-low of $4.49. Sterling Bancorp closed at $5.28 at the end of the last trading period.

    According to Exane BNP Paribas, the prior rating for Alphabet Inc (NASDAQ:GOOGL) was changed from Neutral to Outperform. In the fourth quarter, Alphabet showed an EPS of $1.05, compared to $1.53 from the year-ago quarter. The stock has a 52-week-high of $143.75 and a 52-week-low of $83.34. At the end of the last trading period, Alphabet closed at $100.32.

    According to Wells Fargo, the prior rating for Warner Bros. Discovery Inc (NASDAQ:WBD) was changed from Equal-Weight to Overweight. For the fourth quarter, Warner Bros. Discovery had an EPS of $0.37, compared to year-ago quarter EPS of $0.08. The current stock performance of Warner Bros. Discovery shows a 52-week-high of $27.50 and a 52-week-low of $8.82. Moreover, at the end of the last trading period, the closing price was at $14.16.

    Baird upgraded the previous rating for Applied Industrial Technologies Inc (NYSE:AIT) from Neutral to Outperform. For the second quarter, Applied Industrial had an EPS of $2.22, compared to year-ago quarter EPS of $1.55. At the moment, the stock has a 52-week-high of $149.42 and a 52-week-low of $88.20. Applied Industrial closed at $134.32 at the end of the last trading period.

    For LivePerson Inc (NASDAQ:LPSN), Credit Suisse upgraded the previous rating of Underweight to Neutral. LivePerson earned $0.25 in the fourth quarter, compared to $0.62 in the year-ago quarter. The stock has a 52-week-high of $26.64 and a 52-week-low of $4.02. At the end of the last trading period, LivePerson closed at $4.13.

    For Chubb Ltd (NYSE:CB), JP Morgan upgraded the previous rating of Neutral to Overweight. For the fourth quarter, Chubb had an EPS of $4.05, compared to year-ago quarter EPS of $3.81. The stock has a 52-week-high of $231.37 and a 52-week-low of $173.88. At the end of the last trading period, Chubb closed at $191.86.

    Oppenheimer upgraded the previous rating for Synchrony Financial (NYSE:SYF) from Perform to Outperform. In the fourth quarter, Synchrony Finl showed an EPS of $1.26, compared to $1.48 from the year-ago quarter. At the moment, the stock has a 52-week-high of $41.87 and a 52-week-low of $27.22. Synchrony Finl closed at $29.16 at the end of the last trading period.

    Keefe, Bruyette & Woods upgraded the previous rating for Fidelity National Information Services Inc (NYSE:FIS) from Market Perform to Outperform. For the fourth quarter, Fidelity National Info had an EPS of $1.71, compared to year-ago quarter EPS of $1.92. The stock has a 52-week-high of $106.64 and a 52-week-low of $49.14. At the end of the last trading period, Fidelity National Info closed at $52.15.

    For NVIDIA Corp (NASDAQ:NVDA), Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. For the fourth quarter, NVIDIA had an EPS of $0.88, compared to year-ago quarter EPS of $1.32. At the moment, the stock has a 52-week-high of $289.34 and a 52-week-low of $108.14. NVIDIA closed at $255.41 at the end of the last trading period.

    See all analyst ratings upgrades.

    Downgrades

    UBS downgraded the previous rating for Braze Inc (NASDAQ:BRZE) from Buy to Neutral. In the third quarter, Braze showed an EPS of $0.15, compared to $0.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $50.96 and a 52-week-low of $22.62. Braze closed at $33.15 at the end of the last trading period.

    Guggenheim downgraded the previous rating for AEye Inc (NASDAQ:LIDR) from Buy to Neutral. AEye earned $0.11 in the fourth quarter, compared to $0.13 in the year-ago quarter. The stock has a 52-week-high of $6.33 and a 52-week-low of $0.40. At the end of the last trading period, AEye closed at $0.45.

    According to Argus Research, the prior rating for Bath & Body Works Inc (NYSE:BBWI) was changed from Buy to Hold. For the fourth quarter, Bath & Body Works had an EPS of $1.86, compared to year-ago quarter EPS of $2.30. The stock has a 52-week-high of $57.90 and a 52-week-low of $25.81. At the end of the last trading period, Bath & Body Works closed at $35.25.

    For Ondas Holdings Inc (NASDAQ:ONDS), Oppenheimer downgraded the previous rating of Outperform to Perform. In the fourth quarter, Ondas Holdings showed an EPS of $0.44, compared to $0.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $8.30 and a 52-week-low of $1.32. Ondas Holdings closed at $1.46 at the end of the last trading period.

    According to Oppenheimer, the prior rating for QualTek Services Inc (NASDAQ:QTEK) was changed from Outperform to Perform. At the moment, the stock has a 52-week-high of $3.78 and a 52-week-low of $0.27. QualTek Services closed at $0.28 at the end of the last trading period.

    Gordon Haskett downgraded the previous rating for Dollar General Corp (NYSE:DG) from Accumulate to Hold. Dollar Gen earned $2.96 in the fourth quarter, compared to $2.57 in the year-ago quarter. At the moment, the stock has a 52-week-high of $262.07 and a 52-week-low of $183.25. Dollar Gen closed at $212.09 at the end of the last trading period.

    According to Atlantic Equities, the prior rating for First Republic Bank (NYSE:FRC) was changed from Overweight to Neutral. In the fourth quarter, First Republic Bank showed an EPS of $1.88, compared to $2.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $174.19 and a 52-week-low of $17.53. First Republic Bank closed at $34.27 at the end of the last trading period.

    Keefe, Bruyette & Woods downgraded the previous rating for Bread Financial Holdings Inc (NYSE:BFH) from Outperform to Market Perform. Bread Finl Hldgs earned $2.68 in the fourth quarter, compared to $1.21 in the year-ago quarter. The current stock performance of Bread Finl Hldgs shows a 52-week-high of $60.72 and a 52-week-low of $28.94. Moreover, at the end of the last trading period, the closing price was at $31.46.

    For Kaleyra Inc (NYSE:KLR), Oppenheimer downgraded the previous rating of Outperform to Perform. At the moment, the stock has a 52-week-high of $24.85 and a 52-week-low of $2.00. Kaleyra closed at $2.18 at the end of the last trading period.

    For DigitalOcean Holdings Inc (NYSE:DOCN), Oppenheimer downgraded the previous rating of Outperform to Perform. In the fourth quarter, DigitalOcean Holdings showed an EPS of $0.28, compared to $0.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $63.14 and a 52-week-low of $23.39. DigitalOcean Holdings closed at $35.05 at the end of the last trading period.

    JP Morgan downgraded the previous rating for Cerevel Therapeutics Holdings Inc (NASDAQ:CERE) from Overweight to Neutral. For the fourth quarter, Cerevel Therapeutics Hldg had an EPS of $0.59, compared to year-ago quarter EPS of $0.40. The current stock performance of Cerevel Therapeutics Hldg shows a 52-week-high of $41.43 and a 52-week-low of $19.88. Moreover, at the end of the last trading period, the closing price was at $24.32.

    For NovoCure Ltd (NASDAQ:NVCR), JP Morgan downgraded the previous rating of Neutral to Underweight. NovoCure earned $0.36 in the fourth quarter, compared to $0.25 in the year-ago quarter. At the moment, the stock has a 52-week-high of $120.03 and a 52-week-low of $56.39. NovoCure closed at $64.43 at the end of the last trading period.

    JP Morgan downgraded the previous rating for Emergent BioSolutions Inc (NYSE:EBS) from Neutral to Underweight. In the fourth quarter, Emergent BioSolutions showed an EPS of $0.31, compared to $4.50 from the year-ago quarter. The stock has a 52-week-high of $45.02 and a 52-week-low of $9.17. At the end of the last trading period, Emergent BioSolutions closed at $9.65.

    Truist Securities downgraded the previous rating for Veeva Systems Inc (NYSE:VEEV) from Buy to Hold. In the fourth quarter, Veeva Sys showed an EPS of $1.15, compared to $0.90 from the year-ago quarter. The current stock performance of Veeva Sys shows a 52-week-high of $232.26 and a 52-week-low of $151.06. Moreover, at the end of the last trading period, the closing price was at $175.78.

    According to Wedbush, the prior rating for First Republic Bank (NYSE:FRC) was changed from Outperform to Neutral. For the fourth quarter, First Republic Bank had an EPS of $1.88, compared to year-ago quarter EPS of $2.02. The current stock performance of First Republic Bank shows a 52-week-high of $174.19 and a 52-week-low of $17.53. Moreover, at the end of the last trading period, the closing price was at $34.27.

    For Qualtrics International Inc (NASDAQ:XM), Exane BNP Paribas downgraded the previous rating of Outperform to Neutral. In the fourth quarter, Qualtrics International showed an EPS of $0.03, compared to $0.07 from the year-ago quarter. The stock has a 52-week-high of $30.91 and a 52-week-low of $9.32. At the end of the last trading period, Qualtrics International closed at $17.69.

    According to B of A Securities, the prior rating for Terex Corp (NYSE:TEX) was changed from Buy to Neutral. For the fourth quarter, Terex had an EPS of $1.34, compared to year-ago quarter EPS of $0.82. The stock has a 52-week-high of $60.85 and a 52-week-low of $26.69. At the end of the last trading period, Terex closed at $49.68.

    For Macrogenics Inc (NASDAQ:MGNX), Guggenheim downgraded the previous rating of Buy to Neutral. In the fourth quarter, Macrogenics showed an EPS of $0.21, compared to $0.95 from the year-ago quarter. The stock has a 52-week-high of $10.20 and a 52-week-low of $2.13. At the end of the last trading period, Macrogenics closed at $6.99.

    According to Oppenheimer, the prior rating for RingCentral Inc (NYSE:RNG) was changed from Outperform to Perform. RingCentral earned $0.60 in the fourth quarter, compared to $0.39 in the year-ago quarter. At the moment, the stock has a 52-week-high of $129.51 and a 52-week-low of $28.00. RingCentral closed at $31.97 at the end of the last trading period.

    According to Telsey Advisory Group, the prior rating for The Honest Co Inc (NASDAQ:HNST) was changed from Outperform to Market Perform. For the fourth quarter, Honest Co had an EPS of $0.14, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $6.16 and a 52-week-low of $1.82. At the end of the last trading period, Honest Co closed at $1.86.

    For Synchrony Financial (NYSE:SYF), Keefe, Bruyette & Woods downgraded the previous rating of Market Outperform to Market Perform. For the fourth quarter, Synchrony Finl had an EPS of $1.26, compared to year-ago quarter EPS of $1.48. The current stock performance of Synchrony Finl shows a 52-week-high of $41.87 and a 52-week-low of $27.22. Moreover, at the end of the last trading period, the closing price was at $29.16.

    According to Cantor Fitzgerald, the prior rating for REE Automotive Ltd (NASDAQ:REE) was changed from Overweight to Neutral. For the fourth quarter, REE Automotive had an EPS of $0.07, compared to year-ago quarter EPS of $0.09. At the moment, the stock has a 52-week-high of $2.56 and a 52-week-low of $0.29. REE Automotive closed at $0.38 at the end of the last trading period.

    See all analyst ratings downgrades.

    Initiations

    Maxim Group initiated coverage on Zevra Therapeutics Inc (NASDAQ:ZVRA) with a Buy rating. The price target for Zevra Therapeutics is set to $12.00. In the fourth quarter, Zevra Therapeutics showed an EPS of $0.26, compared to $0.08 from the year-ago quarter. The current stock performance of Zevra Therapeutics shows a 52-week-high of $6.92 and a 52-week-low of $4.00. Moreover, at the end of the last trading period, the closing price was at $4.71.

    BTIG initiated coverage on Seadrill Ltd (NYSE:SDRL) with a Buy rating. The price target for Seadrill is set to $50.00. Seadrill earned $0.36 in the third quarter, compared to $0.55 in the year-ago quarter. The stock has a 52-week-high of $45.48 and a 52-week-low of $24.51. At the end of the last trading period, Seadrill closed at $35.80.

    Stifel initiated coverage on Inventiva SA (NASDAQ:IVA) with a Buy rating. The price target for Inventiva is set to $27.00. None

    Citigroup initiated coverage on Bumble Inc (NASDAQ:BMBL) with a Buy rating. The price target for Bumble is set to $24.00. Bumble earned $0.23 in the fourth quarter, compared to $0.08 in the year-ago quarter. At the moment, the stock has a 52-week-high of $39.31 and a 52-week-low of $17.62. Bumble closed at $19.37 at the end of the last trading period.

    With a Buy rating, Truist Securities initiated coverage on Churchill Downs Inc (NASDAQ:CHDN). The price target seems to have been set at $300.00 for Churchill Downs. For the fourth quarter, Churchill Downs had an EPS of $1.46, compared to year-ago quarter EPS of $1.27. The current stock performance of Churchill Downs shows a 52-week-high of $253.29 and a 52-week-low of $172.75. Moreover, at the end of the last trading period, the closing price was at $243.89.

    With a Buy rating, Truist Securities initiated coverage on IQVIA Holdings Inc (NYSE:IQV). The price target seems to have been set at $265.00 for IQVIA Hldgs. IQVIA Hldgs earned $2.78 in the fourth quarter, compared to $2.55 in the year-ago quarter. The current stock performance of IQVIA Hldgs shows a 52-week-high of $254.88 and a 52-week-low of $165.75. Moreover, at the end of the last trading period, the closing price was at $196.43.

    SVB Leerink initiated coverage on Centessa Pharmaceuticals PLC (NASDAQ:CNTA) with an Outperform rating. The price target for Centessa Pharmaceuticals is set to $6.00. In the third quarter, Centessa Pharmaceuticals showed an EPS of $0.57, compared to $0.45 from the year-ago quarter. The current stock performance of Centessa Pharmaceuticals shows a 52-week-high of $9.91 and a 52-week-low of $2.90. Moreover, at the end of the last trading period, the closing price was at $4.00.

    SVB Leerink initiated coverage on PTC Therapeutics Inc (NASDAQ:PTCT) with a Market Perform rating. The price target for PTC Therapeutics is set to $48.00. For the fourth quarter, PTC Therapeutics had an EPS of $1.89, compared to year-ago quarter EPS of $2.03. At the moment, the stock has a 52-week-high of $55.52 and a 52-week-low of $25.04. PTC Therapeutics closed at $48.10 at the end of the last trading period.

    Cantor Fitzgerald initiated coverage on Galecto Inc (NASDAQ:GLTO) with an Overweight rating. The price target for Galecto is set to $16.00. Galecto earned $0.55 in the fourth quarter, compared to $0.53 in the year-ago quarter. The stock has a 52-week-high of $2.95 and a 52-week-low of $1.06. At the end of the last trading period, Galecto closed at $1.76.

    Capital One initiated coverage on Zscaler Inc (NASDAQ:ZS) with a Equal-Weight rating. The price target for Zscaler is set to $125.00. For the second quarter, Zscaler had an EPS of $0.37, compared to year-ago quarter EPS of $0.13. The current stock performance of Zscaler shows a 52-week-high of $253.72 and a 52-week-low of $99.64. Moreover, at the end of the last trading period, the closing price was at $108.13.

    With a Buy rating, Citigroup initiated coverage on Atour Lifestyle Holdings Ltd (NASDAQ:ATAT). The price target seems to have been set at $28.30 for Atour Lifestyle Holdings. The current stock performance of Atour Lifestyle Holdings shows a 52-week-high of $29.40 and a 52-week-low of $11.05. Moreover, at the end of the last trading period, the closing price was at $24.08.

    With a Buy rating, WestPark Capital initiated coverage on Okta Inc (NASDAQ:OKTA). The price target seems to have been set at $120.00 for Okta. Okta earned $0.30 in the fourth quarter, compared to $0.18 in the year-ago quarter. The current stock performance of Okta shows a 52-week-high of $176.02 and a 52-week-low of $44.13. Moreover, at the end of the last trading period, the closing price was at $84.36.

    Baird initiated coverage on BILL Holdings Inc (NYSE:BILL) with a Neutral rating. The price target for BILL Holdings is set to $86.00. BILL Holdings earned $0.42 in the second quarter, compared to $0.00 in the year-ago quarter. The current stock performance of BILL Holdings shows a 52-week-high of $244.89 and a 52-week-low of $68.30. Moreover, at the end of the last trading period, the closing price was at $76.63.

    With a Buy rating, Stifel initiated coverage on Viking Therapeutics Inc (NASDAQ:VKTX). The price target seems to have been set at $22.00 for Viking Therapeutics. In the fourth quarter, Viking Therapeutics showed an EPS of $0.26, compared to $0.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.98 and a 52-week-low of $2.02. Viking Therapeutics closed at $10.94 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $AAL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAL
    $AIT
    $ATAT
    $BBWI

    CompanyDatePrice TargetRatingAnalyst
    BILL Holdings Inc.
    $BILL
    2/6/2026$50.00 → $46.00Market Perform
    BMO Capital Markets
    DigitalOcean Holdings Inc.
    $DOCN
    2/5/2026$68.00Neutral → Overweight
    Cantor Fitzgerald
    Bread Financial Holdings Inc.
    $BFH
    2/5/2026$90.00In-line → Outperform
    Evercore ISI
    American Airlines Group Inc.
    $AAL
    1/30/2026$19.00 → $17.00Buy
    TD Cowen
    Synchrony Financial
    $SYF
    1/28/2026$96.00Neutral → Buy
    Compass Point
    PTC Therapeutics Inc.
    $PTCT
    1/28/2026$119.00Overweight
    Barclays
    Inventiva S.A.
    $IVA
    1/28/2026$18.00Overweight
    Barclays
    Fidelity National Information Services Inc.
    $FIS
    1/27/2026$72.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $AAL
    $AIT
    $ATAT
    $BBWI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    FDA Approval for MARGENZA issued to MACROGENICS INC

    Submission status for MACROGENICS INC's drug MARGENZA (SUPPL-5) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 05/25/2023. Application Category: BLA, Application Number: 761150, Application Classification:

    5/29/23 4:45:45 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAL
    $AIT
    $ATAT
    $BBWI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Duke Energy leverages AI to protect customers and combat scams

    AI technology proactively scans websites, social media and paid ads to detect scamsCHARLOTTE, N.C., Feb. 12, 2026 /PRNewswire/ -- Duke Energy is advancing its commitment to customer safety by deploying artificial intelligence (AI) to detect scams targeting energy customers. This innovative technology scans websites, social media and paid advertisements for open-source social engineering threats, helping to protect customers from fraudulent schemes. "As scammers become more sophisticated, Duke Energy is proactively working to protect customers from bad actors. Our commitment is

    2/12/26 10:57:00 AM ET
    $DUK
    Power Generation
    Utilities

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, February 26, 2026, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year of 2025. Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent's website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of

    2/12/26 9:02:20 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAL
    $AIT
    $ATAT
    $BBWI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets reiterated coverage on Bill.com with a new price target

    BMO Capital Markets reiterated coverage of Bill.com with a rating of Market Perform and set a new price target of $46.00 from $50.00 previously

    2/6/26 6:48:02 AM ET
    $BILL
    EDP Services
    Technology

    DigitalOcean upgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald upgraded DigitalOcean from Neutral to Overweight and set a new price target of $68.00

    2/5/26 6:50:53 AM ET
    $DOCN
    Computer Software: Programming Data Processing
    Technology

    Bread Financial upgraded by Evercore ISI with a new price target

    Evercore ISI upgraded Bread Financial from In-line to Outperform and set a new price target of $90.00

    2/5/26 6:50:02 AM ET
    $BFH
    Real Estate

    $AAL
    $AIT
    $ATAT
    $BBWI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bruno Julianne converted options into 129,000 shares, increasing direct ownership by 1,606% to 137,032 units (SEC Form 4)

    4 - Galecto, Inc. (0001800315) (Issuer)

    2/12/26 6:05:08 AM ET
    $GLTO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fairmount Funds Management Llc converted options into 8,713,000 shares (SEC Form 4)

    4 - Galecto, Inc. (0001800315) (Issuer)

    2/12/26 6:03:41 AM ET
    $GLTO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Herd Whitney Wolfe covered exercise/tax liability with 4,632 shares, decreasing direct ownership by 0.29% to 1,578,554 units (SEC Form 4)

    4 - Bumble Inc. (0001830043) (Issuer)

    2/11/26 5:27:19 PM ET
    $BMBL
    Computer Software: Programming Data Processing
    Technology

    $AAL
    $AIT
    $ATAT
    $BBWI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $AAL
    $AIT
    $ATAT
    $BBWI
    SEC Filings

    View All

    Director Goldstein Jeffrey A bought $60,328 worth of shares (941 units at $64.11), increasing direct ownership by 7% to 14,529 units (SEC Form 4)

    4 - Fidelity National Information Services, Inc. (0001136893) (Issuer)

    1/20/26 4:59:47 PM ET
    $FIS
    Real Estate

    Director Nash Sarah E bought $155,800 worth of shares (10,000 units at $15.58), increasing direct ownership by 4% to 285,522 units (SEC Form 4)

    4 - Bath & Body Works, Inc. (0000701985) (Issuer)

    11/25/25 4:16:41 PM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Director Symancyk James Kevin bought $350,550 worth of shares (22,500 units at $15.58), increasing direct ownership by 126% to 40,379 units (SEC Form 4)

    4 - Bath & Body Works, Inc. (0000701985) (Issuer)

    11/25/25 4:16:42 PM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Ondas Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

    8-K - Ondas Inc. (0001646188) (Filer)

    2/12/26 10:43:49 AM ET
    $ONDS
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Terex Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - TEREX CORP (0000097216) (Filer)

    2/12/26 10:39:21 AM ET
    $TEX
    Construction/Ag Equipment/Trucks
    Industrials

    SEC Form 424B7 filed by Ondas Inc.

    424B7 - Ondas Inc. (0001646188) (Filer)

    2/12/26 9:37:56 AM ET
    $ONDS
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $AAL
    $AIT
    $ATAT
    $BBWI
    Financials

    Live finance-specific insights

    View All

    Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, February 26, 2026, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year of 2025. Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent's website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of

    2/12/26 9:02:20 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dollar General Corporation Announces Webcast of its Fourth Quarter 2025 Earnings Conference Call

    Dollar General Corporation (NYSE:DG) today announced that it plans to release its financial results for the fiscal 2025 fourth quarter and full year ended January 30, 2026, on March 12, 2026. In connection with the release, Todd Vasos, chief executive officer, and Donny Lau, chief financial officer, will host a conference call on March 12, 2026, at 8:00 a.m. CT/9:00 a.m. ET. During the call, the company will discuss the earnings results and may discuss material business, financial or other information that is not contained in the earnings release. To participate via telephone, please call (877) 407-0890 at least 10 minutes before the conference call is scheduled to begin. The conferen

    2/12/26 6:55:00 AM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary

    Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update

    Conference call scheduled for 4:30 p.m. ET today Oral VK2735 to Advance into Phase 3 for Obesity in 3Q26Phase 3 VANQUISH Trials for Subcutaneous VK2735 in Obesity Ongoing; VANQUISH-1 Enrollment Complete, VANQUISH-2 Nearing Full EnrollmentVK2735 Maintenance Dosing Study Fully Enrolled; Data Expected 3Q26Novel Amylin Agonist IND Filing Planned This Quarter Strong Quarter-End Cash Position of $706 MillionSAN DIEGO, Feb. 11, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial results for the fourth quarter and year ended

    2/11/26 4:16:00 PM ET
    $VKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAL
    $AIT
    $ATAT
    $BBWI
    Leadership Updates

    Live Leadership Updates

    View All

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    RingCentral Set to Join S&P SmallCap 600

    NEW YORK, Feb. 9, 2026 /PRNewswire/ -- RingCentral Inc. (NYSE:RNG) will replace Hillenbrand Inc. (NYSE:HI) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, February 12. Lone Star Funds is acquiring Hillenbrand in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Feb 12, 2026 S&P SmallCap 600 Addition RingCentral RNG Information Technology Feb 12, 2026 S&P SmallCap 600 Deletion Hillenbrand HI Industrials ABOUT S&P DOW JONES INDICES S&P Dow Jones Indices is the large

    2/9/26 6:08:00 PM ET
    $HI
    $RNG
    $SPGI
    Miscellaneous manufacturing industries
    Consumer Discretionary
    EDP Services
    Technology

    FMC Corporation sets 2026 priorities and announces exploration of strategic options including but not limited to the sale of the company

    Company reports 2025 fourth quarter and full year results, provides 2026 outlook  The organization continues to focus on its 2026 operational priorities, including strengthening the balance sheet, improving the competitiveness of its core portfolio, managing its post-patent Rynaxypyr® active strategy and supporting growth of new active ingredientsThe FMC Board of Directors has authorized the exploration of strategic options, including but not limited to, the sale of the company to unlock shareholder value and ensure its growth and core portfolios are best positioned for long-term success PHILADELPHIA, Feb. 4, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced its 2026 prioritie

    2/4/26 5:00:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    $AAL
    $AIT
    $ATAT
    $BBWI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by RingCentral Inc.

    SC 13G - RingCentral, Inc. (0001384905) (Subject)

    11/21/24 6:08:56 AM ET
    $RNG
    EDP Services
    Technology

    SEC Form SC 13G filed by MacroGenics Inc.

    SC 13G - MACROGENICS INC (0001125345) (Subject)

    11/20/24 10:44:27 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Honest Company Inc.

    SC 13G/A - Honest Company, Inc. (0001530979) (Subject)

    11/14/24 6:19:57 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary